Dr. Anjali Budhathoki, MD

Dr. Budhathoki practices at Emplify Health Green Bay Hospital in Green Bay, Wisconsin, part of Emplify Health.

Dr. Budhathoki's NPI, 1548558166, was assigned on July 17, 2011. Dr. Budhathoki holds New York license 316716.

Dr. Budhathoki's primary practice is Emplify Health Green Bay Hospital, at 744 S Webster Ave, Green Bay, WI 54301 in Brown County. The practice phone is (920) 433-3500.

Dr. Budhathoki's primary practice is Emplify Health Green Bay Hospital in Green Bay, Wisconsin, part of Emplify Health. Dr. Budhathoki is also affiliated with Aurora Medical Center - Bay Area. The medical group on file is Bellin Health Heart & Vascular Crystal Falls. Dmand AI also links Dr. Budhathoki to 2 more hospitals, 2 group practices and clinics, 2 medical groups and 1 imaging center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Budhathoki practices, 7 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Budhathoki's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Budhathoki's licenses on file in 3 states: New York, Massachusetts and Wisconsin.

CMS data shows 138 Medicare services from Dr. Budhathoki across 3 procedure codes in 2024, for 94 Medicare patients. Medicare paid $11,679 for them.

CMS counts 94 Medicare patients who saw Dr. Budhathoki in 2024. The largest group is 65 to 74, with 45 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 2.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Budhathoki's median patient age at 70, with 61% women.

In 2024, Dr. Budhathoki wrote 320 Medicare Part D claims for 107 patients. 76% of them were for generic drugs. CMS names the drug for 166 of them, across 10 drugs with 11 or more claims each, at $690,528 in total drug cost. In 2023, CMS named 12 claims across 1 drug.

Dr. Budhathoki accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 8 papers to Dr. Budhathoki, published from 2017 to 2025. 2017 was the busiest year, with 6. The most frequent topics are Myelodysplastic Syndromes. Dr. Budhathoki has published most often in Am J Hematol. Dr. Budhathoki's most frequent co-authors are Ira J. Braunschweig, MD, Murali Janakiram, MD and Aditi Shastri, MD.

CMS Open Payments shows 15 general payments to Dr. Budhathoki from 6 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 91% of the total. Pfizer Inc. paid the most, $4,083.